These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7183446)

  • 1. [Results of treatment of hirsutism with spironolactone].
    Baranowska B; Stopińska-Głuszak U; Niewiadomska A; Zgliczyński S
    Endokrynol Pol; 1982; 33(1-3):93-8. PubMed ID: 7183446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
    Suraci C; Costa C; De Pedrini P
    Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel use of spironolactone: treatment of hirsutism.
    Shapiro G; Evron S
    J Clin Endocrinol Metab; 1980 Sep; 51(3):429-32. PubMed ID: 7410528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism.
    Messina M; Manieri C; Biffignandi P; Massucchetti C; Novi RF; Molinatti GM
    J Endocrinol Invest; 1983 Feb; 6(1):23-7. PubMed ID: 6404979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence rate of hirsutism after 3 different antiandrogen therapies.
    Yücelten D; Erenus M; Gürbüz O; Durmuşoğlu F
    J Am Acad Dermatol; 1999 Jul; 41(1):64-8. PubMed ID: 10411413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of spironolactone on hirsutism and female androgen metabolism.
    Dorrington-Ward P; McCartney AC; Holland S; Scully J; Carter G; Alaghband-Zadeh J; Wise P
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):161-7. PubMed ID: 4053414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
    Keleştimur F; Everest H; Unlühizarci K; Bayram F; Sahin Y
    Eur J Endocrinol; 2004 Mar; 150(3):351-4. PubMed ID: 15012621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of hirsutism in adolescent girls with spironolactone].
    Malinova M
    Akush Ginekol (Sofiia); 1999; 38(4):28-30. PubMed ID: 10726349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose spironolactone in the treatment of female hyperandrogenemia and hirsutism.
    Vĕtr M; Sobek A
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():55-7. PubMed ID: 7976677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hirsutism with spironolactone.
    Cumming DC; Yang JC; Rebar RW; Yen SS
    JAMA; 1982 Mar; 247(9):1295-8. PubMed ID: 7199587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
    Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
    Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone and estrogen-progestin therapy for hirsutism.
    Board JA; Rosenberg SM; Smeltzer JS
    South Med J; 1987 Apr; 80(4):483-6. PubMed ID: 3563583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome.
    Evans DJ; Burke CW
    J R Soc Med; 1986 Aug; 79(8):451-3. PubMed ID: 3761287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spironolactone in idiopathic hirsutism, clinical and biological evaluation of treatment].
    Abramovici Y; Guillet F; Matte R; Chaieb L; Belanger R
    Ann Endocrinol (Paris); 1983; 44(6):393-6. PubMed ID: 6430208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
    Unlühizarci K K; Everest H; Bayram F; Keleştimur F
    Fertil Steril; 2002 Dec; 78(6):1331-3. PubMed ID: 12477537
    [No Abstract]   [Full Text] [Related]  

  • 19. Spironolactone in the treatment of hirsutism.
    Köksal A; Pabuçcu R; Akyürek C
    Arch Gynecol; 1987; 240(2):95-100. PubMed ID: 3105474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose spironolactone in the treatment of female hirsutism.
    Ylöstalo P; Heikkinen J; Kauppila A; Pakarinen A; Järvinen PA
    Int J Fertil; 1987; 32(1):41-5. PubMed ID: 2880814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.